Inhibitors of checkpoint kinases

The instant invention provides for compounds which comprise substituted pyridyl aminothiazoles that inhibit CHK1 activity. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting CHK1 activity by administering the compound to a patient in need of t...

Full description

Saved in:
Bibliographic Details
Main Authors FRALEY MARK E, KREATSOULAS CONSTANTINE, ARRINGTON KENNETH L, WANG CHENG, DUDKIN VADIM Y, HOFFMAN JACOB M
Format Patent
LanguageEnglish
Published 17.09.2009
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The instant invention provides for compounds which comprise substituted pyridyl aminothiazoles that inhibit CHK1 activity. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting CHK1 activity by administering the compound to a patient in need of treatment of cancer.
AbstractList The instant invention provides for compounds which comprise substituted pyridyl aminothiazoles that inhibit CHK1 activity. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting CHK1 activity by administering the compound to a patient in need of treatment of cancer.
Author ARRINGTON KENNETH L
WANG CHENG
HOFFMAN JACOB M
KREATSOULAS CONSTANTINE
DUDKIN VADIM Y
FRALEY MARK E
Author_xml – fullname: FRALEY MARK E
– fullname: KREATSOULAS CONSTANTINE
– fullname: ARRINGTON KENNETH L
– fullname: WANG CHENG
– fullname: DUDKIN VADIM Y
– fullname: HOFFMAN JACOB M
BookMark eNrjYmDJy89L5WRQ8MzLyEzKLMkvKlbIT1NIzkhNzi7Iz8wrUcjOzEssTi3mYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBgaWRsbGFpZmjobGxKkCAN_BKDM
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2009233896A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2009233896A13
IEDL.DBID EVB
IngestDate Fri Jul 19 16:01:54 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2009233896A13
Notes Application Number: US20060921598
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090917&DB=EPODOC&CC=US&NR=2009233896A1
ParticipantIDs epo_espacenet_US2009233896A1
PublicationCentury 2000
PublicationDate 20090917
PublicationDateYYYYMMDD 2009-09-17
PublicationDate_xml – month: 09
  year: 2009
  text: 20090917
  day: 17
PublicationDecade 2000
PublicationYear 2009
Score 2.7398677
Snippet The instant invention provides for compounds which comprise substituted pyridyl aminothiazoles that inhibit CHK1 activity. The invention also provides for...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Inhibitors of checkpoint kinases
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090917&DB=EPODOC&locale=&CC=US&NR=2009233896A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSUwGJhNjizTd1FRjI10TS5MUXWAtaKKblppmYpRoZGaUYgnaO-zrZ-YRauIVYRrBxJAD2wsDPie0HHw4IjBHJQPzewm4vC5ADGK5gNdWFusnZQKF8u3dQmxd1GC9Y0tg9Weu5uJk6xrg7-LvrObsbBsarOYXBJYzAnbHLM0cgX0lVlBDGnTSvmuYE2hfSgFypeImyMAWADQvr0SIgSk1T5iB0xl295owA4cvdMobyITmvmIRBgXPvIzMpEzQ_TgK-WkKwOBOzi7Iz8wrUcjOzAPWRsWiDMpuriHOHrpAq-LhPosPDUZ2l7EYAwuwz58qwaAAug7D0sI8LRk08WVimmhpkAosutLMk9PSgHV-kqEkgww-k6TwS0szcEEmRSx1Dc1lGFhKikpTZYF1a0mSHDhIAE3ye8c
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1RT4MwEL4s0zjfdGqcTiXR8EZ0wGB9IMbBCNPBFgdmb2SwNpIZIILx73vFoXvaW9Mm1_bSu6_X690B3C1jPCbKgEmUKrKkEnUlIQqqEqNMlZeyJq8Ijx12Pc0J1OdFf9GAjzoWpsoT-l0lR0SJilHey0pf5_-PWFb1t7K4jxLsyh5t37DE2jomCH-6aA2N0WxqTU3RNI1gLnqv1ZiM5hjRntBW2tN5fl5-eXob8riUfBtU7CPYnyG9tDyGBk3b0DLr2mttOHA3Lm9sbqSvOAFhnL4nUcLr4wgZE5Dd8TrPkrQU1kmKaFScwq098k1HwqnCv52FwXx7XcoZNNHmp-cg8HIYZKCzmDu-1P6SPFBUXUyPGUPMj3od6O6idLF7-AZaju9OwsnYe7mEw18HCZF6ehea5ecXvUKcLaPrij0_P15-tA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Inhibitors+of+checkpoint+kinases&rft.inventor=FRALEY+MARK+E&rft.inventor=KREATSOULAS+CONSTANTINE&rft.inventor=ARRINGTON+KENNETH+L&rft.inventor=WANG+CHENG&rft.inventor=DUDKIN+VADIM+Y&rft.inventor=HOFFMAN+JACOB+M&rft.date=2009-09-17&rft.externalDBID=A1&rft.externalDocID=US2009233896A1